Gennova's mRNA vaccine in legal storm after HDT Bio Corp sues Emcure

The US firm HDT Bio Corp has alleged that Emcure 'willfully and maliciously' violated the Defend Trade Secrets Act and Washington's laws against trade secret theft

emcure
Premium

.

Sohini Das Mumbai
Pune-based Gennova Biopharmaceuticals' mRNA Covid-19 vaccine is in the eye of the storm after US based start-up HDT Bio Corp filed a lawsuit in a Seattle federal court against Gennova’s parent company Emcure Pharmaceuticals. HDT has accused Emcure of ‘stealing’ and misappropriation of HDT’s billion dollar trade secrets and sought $950 million in damages.

The US firm has alleged that Emcure ‘willfully and maliciously’ violated the Defend Trade Secrets Act and Washington’s laws against trade secret theft. Emcure Pharma did not immediately respond to the queries.

A spokesperson with Emcure said the licence agreement, which is the subject matter of

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 25 2022 | 11:01 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com